Related Experiment Video
Updated: Jun 10, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Evaluating time-to-event surrogates for time-to-event true endpoints: an information-theoretic approach based on
Florian Stijven1, Geert Molenberghs2,3, Ingrid Van Keilegom4
1KU Leuven, I-BioStat, Leuven, B-3000, Belgium. florian.stijven@kuleuven.be.
This study introduces advanced statistical methods for evaluating surrogate endpoints in clinical trials, particularly for time-to-event data. New techniques improve causal inference for surrogate endpoint assessment, enhancing trial reliability.
Area of Science:
- Biostatistics
- Clinical Trial Methodology
- Causal Inference
Background:
- Rigorous statistical evaluation is crucial for surrogate endpoints in clinical trials.
- Existing frameworks for surrogate endpoint evaluation have limitations.
- Time-to-event endpoints present unique challenges in causal inference.
Purpose of the Study:
- To extend information-theoretic causal inference for time-to-event surrogate endpoints.
- To introduce and evaluate a rank-based metric for the individual causal association (ICA).
- To address identifiability issues in causal inference using sensitivity analysis.
Main Methods:
- Utilized D-vine copulas for modeling joint distributions of time-to-event outcomes.
- Employed mutual information to define the individual causal association (ICA).
- Developed a rank-based metric as an alternative to the standard ICA for composite endpoints.
- Implemented sensitivity analysis to quantify uncertainty and ignorance in ICA estimation.
Main Results:
- Proposed methods effectively evaluate surrogate endpoints for time-to-event data.
- The rank-based metric provides a robust alternative for composite endpoints.
- Sensitivity analysis yields intervals of ignorance and uncertainty for ICA.
- The R package 'Surrogate' implements the developed techniques.
Conclusions:
- The extended causal-inference approach offers a robust framework for surrogate endpoint validation.
- The proposed methods enhance the statistical rigor of surrogate endpoint selection in clinical trials.
- The 'Surrogate' R package facilitates the application of these advanced statistical techniques.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Kaplan-Meier Approach
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Censoring Survival Data
Assumptions of Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

